In PD, dopaminergic neurons experience heightened oxidative, mitochondrial stress, and α-synuclein pathology, which alters ERK signaling dynamics and interferes with BDNF-mediated neuroprotection. This evidence concerns the gene MAPK1 and Parkinson disease.